1. A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer. (17th January 2023) Authors: Shiota, Masaki; Inoue, Ryo; Tashiro, Kojiro; Kobayashi, Keita; Horiyama, Shizuyo; Kanji, Hiromi; Eto, Masatoshi; Egawa, Shin; Haginaka, Jun; Matsuyama, Hideyasu Journal: Journal of clinical pharmacology Issue: Volume 63:Number 4(2023) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer. Issue 5 (1st April 2022) Authors: Ushijima, Miho; Shiota, Masaki; Matsumoto, Takashi; Kashiwagi, Eiji; Inokuchi, Junichi; Eto, Masatoshi Journal: Cancer science Issue: Volume 113:Issue 5(2022) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Androgen receptor mutations for precision medicine in prostate cancer. Issue 10 (17th August 2022) Authors: Shiota, Masaki; Akamatsu, Shusuke; Tsukahara, Shigehiro; Nagakawa, Shohei; Matsumoto, Takashi; Eto, Masatoshi Journal: Endocrine-related cancer Issue: Volume 29:Issue 10(2022) Page Start: R143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan. (3rd August 2022) Authors: Shiota, Masaki; De Moor, Raf; Koroki, Yosuke; Yu, Dae Young; Wu, David Bin-Chia Journal: Current medical research and opinion Issue: Volume 38:Number 8(2022) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy. (25th May 2022) Authors: Narita, Shintaro; Terada, Naoki; Nomura, Kyoko; Sakamoto, Shinichi; Hatakeyama, Shingo; Kato, Takuma; Matsui, Yoshiyuki; Inokuchi, Junichi; Yokomizo, Akira; Tabata, Ken‐ichi; Shiota, Masaki; Kimura, Takahiro; Kojima, Takahiro; Inoue, Takahiro; Mizowaki, Takashi; Sugimoto, Mikio; Kitamura, Hiroshi... Other Names: Saito Toshihiro investigator.; Yoshimura Koji investigator.; Takahashi Atsushi investigator.; Shimazui Toru investigator.; Goto Takayuki investigator.; Hashimoto Yasuhiro investigator.; Nagumo Yoshiyuki investigator.; Yasumoto Hiroaki investigator.; Mitsuzuka Koji investigator.; Ito Akihiro inves... Journal: International journal of urology Issue: Volume 29:Number 10(2022) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy. Issue 10 (11th May 2019) Authors: Shiota, Masaki; Ushijima, Miho; Imada, Kenjiro; Kashiwagi, Eiji; Takeuchi, Ario; Inokuchi, Junichi; Tatsugami, Katsunori; Kajioka, Shunichi; Eto, Masatoshi Journal: Prostate Issue: Volume 79:Issue 10(2019) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical advantages of robot‐assisted partial nephrectomy versus laparoscopic partial nephrectomy in terms of global and split renal functions: A propensity score‐matched comparative analysis. (3rd March 2021) Authors: Kobayashi, Satoshi; Mutaguchi, Jun; Kashiwagi, Eiji; Takeuchi, Ario; Shiota, Masaki; Inokuchi, Junichi; Eto, Masatoshi Journal: International journal of urology Issue: Volume 28:Number 6(2021) Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer. (8th November 2021) Authors: Shiota, Masaki; Fujimoto, Naohiro; Sekino, Yohei; Tsukahara, Shigehiro; Nagakawa, Shohei; Takamatsu, Dai; Abe, Tatsuro; Kinoshita, Fumio; Ueda, Shohei; Ushijima, Miho; Matsumoto, Takashi; Kashiwagi, Eiji; Inokuchi, Junichi; Uchiumi, Takeshi; Oda, Yoshinao; Eto, Masatoshi Journal: Andrologia Issue: Volume 54:Number 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants. Issue 10 (28th August 2018) Authors: Shiota, Masaki; Dejima, Takashi; Yamamoto, Yoshiaki; Takeuchi, Ario; Imada, Kenjiro; Kashiwagi, Eiji; Inokuchi, Junichi; Tatsugami, Katsunori; Kajioka, Shunichi; Uchiumi, Takeshi; Eto, Masatoshi Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Conceptual assessment of HRQOL among Japanese non‐metastatic castration‐resistant prostate cancer (nmCRPC) patients. (30th June 2022) Authors: Nishimura, Kazuo; Shiota, Masaki; Eto, Masatoshi; Satoh, Takefumi; Stroupe, Angela; Seo, Caroline; Uzumcu, Alyssa; Ledesma, Dianne Athene Journal: Cancer medicine Issue: Volume 12:Number 2(2023) Page Start: 1762 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗